Stockreport

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Prenetics Global Limited - Class A Ordinary Share  (PRE) 
PDF HONG KONG, April 1, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today [Read more]